News

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

Ebola AntigensJawahar Raina
Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles

Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles

Ebola AntigensJawahar Raina
Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice

Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice

Ebola AntigensJawahar Raina
Ebola Virus Causes Intestinal Tract Architectural Disruption and Bacterial Invasion in Non-Human Primates

Ebola Virus Causes Intestinal Tract Architectural Disruption and Bacterial Invasion in Non-Human Primates

Ebola AntigensJawahar Raina
Differential requirements for FcγR engagement by protective antibodies against Ebola virus

Differential requirements for FcγR engagement by protective antibodies against Ebola virus

Ebola AntigensJawahar Raina
ANTIBODY-DEPENDENT ENHANCEMENT OF EBOLA VIRUS INFECTION BY HUMAN ANTIBODIES ISOLATED FROM SURVIVORS

ANTIBODY-DEPENDENT ENHANCEMENT OF EBOLA VIRUS INFECTION BY HUMAN ANTIBODIES ISOLATED FROM SURVIVORS

Ebola AntigensJawahar Raina
Field-Effect Transistor Biosensor for Rapid Detection of Ebola Antigen

Field-Effect Transistor Biosensor for Rapid Detection of Ebola Antigen

Ebola AntigensJawahar Raina
Conserved B and T cell epitopes prediction of ebola virus glycoprotein for vaccine development: An immuno-informatics approach

Conserved B and T cell epitopes prediction of ebola virus glycoprotein for vaccine development: An immuno-informatics approach

Ebola AntigensJawahar Raina
The Final (Oral Ebola) Vaccine Trial on Captive Chimpanzees?

The Final (Oral Ebola) Vaccine Trial on Captive Chimpanzees?

Ebola AntigensJawahar Raina
A thermostable, chromatographically purified Ebola nano-VLP vaccine

A thermostable, chromatographically purified Ebola nano-VLP vaccine

Ebola AntigensJawahar Raina
Analysis of CD8+ T cell response during the 2013–2016 Ebola epidemic in West Africa

Analysis of CD8+ T cell response during the 2013–2016 Ebola epidemic in West Africa

Ebola AntigensJawahar Raina
Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species

Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species

Ebola AntigensJawahar Raina